Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study

Abstract

The neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) are found to increase in patients who develop postoperative complications (PCs). The aim of the present study was to explore the association of the perioperative changes of NLR (ΔNLR) and PLR (ΔPLR) with PCs in non-small cell lung cancer (NSCLC). Clinical data of 509 patients, who were diagnosed with NSCLC and underwent thoracoscopic radical resection between January 1, 2014 and July 31, 2016 at the Department of Thoracic Surgery, West China Hospital, were reviewed. Patients were divided into PC and non-PC groups, and clinical characteristics including ΔNLR and ΔPLR were compared between them. The optimal cut-off values of ΔNLR and ΔPLR were determined by receiver operating characteristics (ROC) curves and patients were assigned to high ΔNLR/ΔPLR and low ΔNLR/ΔPLR groups in terms of the cut-off values. Clinicopathologic characteristics and the incidence of different PCs were compared between the dichotomized groups. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors for PCs. The results showed that the ΔNLR and ΔPLR in the PC group were signifcantly higher than those in the non-PC group (P<0.001 for both). The optimal cutoff values of ΔNLR and ΔPLR were 6.6 and 49, respectively. Patients with ΔNLR>6.6 or ΔPLR>49 were more likely to experience postoperative pulmonary complications (PPCs) (P<0.001 for both). Multivariate logistic regression analysis demonstrated that smoking [odds ratio (OR): 2.450, 95% confdence interval (95% CI): 1.084-5.535, P=0.031)], tumor size (OR: 1.225, 95% CI: 1.047-1.433, P=0.011), ΔNLR>6.6 (OR: 2.453, 95% CI: 1.224-4.914, P=0.011) and ΔPLR>49 (OR: 2.231, 95% CI: 1.182-4.212, P=0.013) were predictive of PPCs. In conclusion, the ΔNLR and ΔPLR may act as novel predictors for PPCs in NSCLC patients undergoing thoracoscopic radical lung resection, and patients with ΔNLR>6.6 or ΔPLR>49 should be treated more actively to prevent or reduce PPCs.

Keywords

neutrophil-to-lymphocyte ratio / platelet-to-lymphocyte ratio / non-small cell lung cancer / postoperative pulmonary complication

References

[1] TorreLA, BrayF, SiegelRL, et al.. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108

[2] FanH, ShaoZY, XiaoYY, et al.. Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study. BMJ Ope, 2015, 5(12): 9419

[3] DelaCC, TanoueLT, MatthayRA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Me, 2011, 32(4): 605-644

[4] SiegelR, DeSantisC, VirgoK, et al.. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 2012, 62(4): 220-241

[5] McKennaRJ, HouckW, FullerCB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg, 2006, 81(2): 421-425

[6] SederCW, HannaK, LuciaV, et al.. The safe transition from open to thoracoscopic lobectomy: a 5-year experience. Ann Thorac Surg, 2009, 88(1): 216-225

[7] WhitsonBA, GrothSS, DuvalSJ, et al.. Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg, 2008, 86(6): 2008-2016

[8] LanH, ZhouL, ChiD, et al.. Preoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: A single institutional cohort study. Oncotarget, 2017, 8(21): 35301-35310

[9] YangJ, XiaY, YangY. Risk Factors for Major Adverse Events of Video-Assisted Thoracic Surgery Lobectomy for Lung Cancer. Int J Med Sci, 2014, 11(9): 863-869

[10] FengZ, WenH, BiR, et al.. Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer. PLoS One, 2016, 11: 156101

[11] MarchioniM, PrimiceriG, IngrossoM, et al.. The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review. Clin Genitourin Cancer, 2016, 14(6): 473-484

[12] MaedaY, KawaharaT, KoizumiM, et al.. Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy. Biomed Res Int, 2016, 2016: 6197353

[13] DermanBA, MacklisJN, AzeemMS, et al.. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. BMC Cancer, 2017, 17(1): 141

[14] ZhuL, ChenS, MaS, et al.. Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis. Springerplus, 2016, 5: 439

[15] AkinciOB, SahinOT, BuyukyaylaciOS, et al.. Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases. Asian Pac J Cancer Prev, 2017, 18(5): 1417-1421

[16] YinY, WangJ, WangX, et al.. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis. Clinics, 2015, 70(7): 524-530

[17] ZhangH, GaoLW, ZhangB, et al.. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep, 2016, 6: 22618

[18] SarrafKM, BelcherE, RaevskyE, et al.. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg, 2009, 137(2): 425-428

[19] WuGN, YaoYW, BaiCQ, et al.. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients. Thorac Cancer, 2015, 6(3): 275-287

[20] BerardiR, RinaldiS, SantoniM, et al.. Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo-or targeted therapy. Oncotarget, 2016, 7(18): 26916-26924

[21] KobayashiN, UsuiS, KikuchiS, et al.. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer, 2012, 75(2): 223-227

[22] FernandezFG, FalcozPE, KozowerBD, et al.. The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons general thoracic surgery databases: joint standardization of variable definitions and terminology. Ann Thorac Surg, 2015, 99(1): 368-376

[23] DindoD, DemartinesN, ClavienPA. Classifcation of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004, 240(2): 205-213

[24] LaiCY, TianL, SchistermanEF. Exact confidence interval estimation for the Youden index and its corresponding optimal cut-point. Comput Stat Data Anal, 2012, 56(5): 1103-1114

[25] ShionoS, AbikoM, SatoT. Postoperative complications in elderly patients after lung cancer surgery. Interact Cardiovasc Thorac Surg, 2013, 16(6): 819-823

[26] SimonsenDF, SøgaardM, BoziI, et al.. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir Med, 2015, 109(10): 1340-1346

[27] OkamiJ, HigashiyamaM, AsamuraH, et al.. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: Prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol, 2009, 4(10): 1247-1253

[28] Dominguez-VenturaA, AllenMS, CassiviSD, et al.. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg, 2006, 82(4): 1175-1179

[29] ZhaoC, DingC, XieT, et al.. Validation and optimization of the Systemic Inflammation-Based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: preliminary data. Sci Rep, 2018, 8(1): 747

[30] InaokaK, KandaM, UdaH, et al.. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol, 2017, 23(14): 2519-2526

[31] AlexanderF, WichatS, LeonF, et al.. The Neutrophil to Lymphocyte Ratio on Admission and Short-Term Outcomes in Orthogeriatric Patients. Int J Med Sci, 2016, 13(8): 588-602

[32] MaestrelliP, SaettaM, MappCE, et al.. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001, 164(10): S76-S80

[33] WalkerTR, KieferJE. Ciliastatic components in the gas phase of cigarette smoke. Science, 1966, 153(741): 1248-1250

[34] WannerA, SalatheM, O’RiordanTG. Mucociliary clearance in the airways. Am J Respir Crit Care Med, 1996, 154(6): 1868-1902

[35] BerensonCS, WronaCT, GroveLJ, et al.. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med, 2006, 174(1): 31-40

[36] KotaniN, HashimotoH, SesslerDI, et al.. Smoking decreases alveolar macrophage function during anesthesia and surgery. Anesthesiology, 2000, 92(5): 1268-1277

[37] NakagawaM, TanakaH, TsukumaH, et al.. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest, 2001, 120(3): 705-710

[38] BlumanLG, MoscaL, NewmanN, et al.. Preoperative smoking habits and postoperative pulmonary complications. Chest, 1998, 113(4): 883-889

[39] OkadaM, NishioW, SakamotoT, et al.. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg, 2005, 129(1): 87-93